GENE ONLINE|News &
Opinion
Blog

RNA Therapeutics
Scientists Engineer RNA Switches for Targeted Delivery of Gene Therapy and RNA Therapeutics
2021-11-07
Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara
2021-08-26
Moderna Banks on Autolus’ Proprietary Tech to Advance Immuno-Oncology Pipeline
2021-08-03
JPM Healthcare Conference: Shape, Korro, and Ionis Present Advances in RNA Therapeutics
2021-01-18
Alnylam Receives FDA Nod for its Third Rare Disease Drug
2020-11-25
New Frontiers in Therapeutics
2020-07-25Partner
A Rising Hope in Therapeutics — From Precision Medicine to Advanced Therapies
2020-07-19
R&D
Biogen’s SMA Drug, Spinraza Continues to Show Benefits in Pre-Symptomatic Patients
2020-06-14
The Rejuvenated Promise of RNA Therapeutics
2020-01-07
RNA Therapeutics: An Overview
2019-12-25
LATEST
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
EVENT
2021-12-13
63rd ASH ANNUAL MEETING AND EXPOSITION
Georgia, USA
2021-12-28
BIOHK2021
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!